123 related articles for article (PubMed ID: 12165543)
1. A spontaneous CD8 T cell-dependent autoimmune disease to an antigen expressed under the human keratin 14 promoter.
McGargill MA; Mayerova D; Stefanski HE; Koehn B; Parke EA; Jameson SC; Panoskaltsis-Mortari A; Hogquist KA
J Immunol; 2002 Aug; 169(4):2141-7. PubMed ID: 12165543
[TBL] [Abstract][Full Text] [Related]
2. Induction of GVHD-like skin disease by passively transferred CD8(+) T-cell receptor transgenic T cells into keratin 14-ovalbumin transgenic mice.
Shibaki A; Sato A; Vogel JC; Miyagawa F; Katz SI
J Invest Dermatol; 2004 Jul; 123(1):109-15. PubMed ID: 15191550
[TBL] [Abstract][Full Text] [Related]
3. The use of mouse models to better understand mechanisms of autoimmunity and tolerance.
Miyagawa F; Gutermuth J; Zhang H; Katz SI
J Autoimmun; 2010 Nov; 35(3):192-8. PubMed ID: 20655706
[TBL] [Abstract][Full Text] [Related]
4. A low affinity TCR ligand restores positive selection of CD8+ T cells in vivo.
Stefanski HE; Mayerova D; Jameson SC; Hogquist KA
J Immunol; 2001 Jun; 166(11):6602-7. PubMed ID: 11359813
[TBL] [Abstract][Full Text] [Related]
5. Urinary bladder epithelium antigen induces CD8+ T cell tolerance, activation, and autoimmune response.
Liu W; Evanoff DP; Chen X; Luo Y
J Immunol; 2007 Jan; 178(1):539-46. PubMed ID: 17182594
[TBL] [Abstract][Full Text] [Related]
6. Soluble peptide treatment reverses CD8 T-cell-induced disease in a mouse model of spontaneous tissue-selective autoimmunity.
Paek SY; Miyagawa F; Zhang H; Linton JT; Hoover SB; Simpson RM; Katz SI
J Invest Dermatol; 2012 Mar; 132(3 Pt 1):677-86. PubMed ID: 22089830
[TBL] [Abstract][Full Text] [Related]
7. The CD8 T cell response to vaccinia virus exhibits site-dependent heterogeneity of functional responses.
Xiao Z; Curtsinger JM; Prlic M; Jameson SC; Mescher MF
Int Immunol; 2007 Jun; 19(6):733-43. PubMed ID: 17545279
[TBL] [Abstract][Full Text] [Related]
8. Nonspecific down-regulation of CD8+ T-cell responses in mice expressing human papillomavirus type 16 E7 oncoprotein from the keratin-14 promoter.
Tindle RW; Herd K; Doan T; Bryson G; Leggatt GR; Lambert P; Frazer IH; Street M
J Virol; 2001 Jul; 75(13):5985-97. PubMed ID: 11390600
[TBL] [Abstract][Full Text] [Related]
9. IL-17A/F enable cholangiocytes to restrict T cell-driven experimental cholangitis by upregulating PD-L1 expression.
Stein S; Henze L; Poch T; Carambia A; Krech T; Preti M; Schuran FA; Reich M; Keitel V; Fiorotto R; Strazzabosco M; Fischer L; Li J; Müller LM; Wagner J; Gagliani N; Herkel J; Schwinge D; Schramm C
J Hepatol; 2021 Apr; 74(4):919-930. PubMed ID: 33197512
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticle-mediated targeting of autoantigen peptide to cross-presenting liver sinusoidal endothelial cells protects from CD8 T-cell-driven autoimmune cholangitis.
Carambia A; Gottwick C; Schwinge D; Stein S; Digigow R; Şeleci M; Mungalpara D; Heine M; Schuran FA; Corban C; Lohse AW; Schramm C; Heeren J; Herkel J
Immunology; 2021 Apr; 162(4):452-463. PubMed ID: 33346377
[TBL] [Abstract][Full Text] [Related]
11. Regulation of cytokine-driven functional differentiation of CD8 T cells by suppressor of cytokine signaling 1 controls autoimmunity and preserves their proliferative capacity toward foreign antigens.
Ramanathan S; Dubois S; Gagnon J; Leblanc C; Mariathasan S; Ferbeyre G; Rottapel R; Ohashi PS; Ilangumaran S
J Immunol; 2010 Jul; 185(1):357-66. PubMed ID: 20519645
[TBL] [Abstract][Full Text] [Related]
12. Self-peptides prolong survival in murine autoimmunity via reduced IL-2/IL-7-mediated STAT5 signaling, CD8 coreceptor, and V alpha 2 down-regulation.
Gutermuth J; Nograles KE; Miyagawa F; Nelson E; Cho YH; Katz SI
J Immunol; 2009 Sep; 183(5):3130-8. PubMed ID: 19675167
[TBL] [Abstract][Full Text] [Related]
13. Selective absence of CD8+ TCRalpha beta+ intestinal epithelial cells in transgenic mice expressing beta2-microglobulin-associated ligands exclusively on thymic cortical epithelium.
Capone M; Lees RK; Finke D; Ernst B; Meerwijk JP; MacDonald HR
Eur J Immunol; 2003 Jun; 33(6):1471-7. PubMed ID: 12778464
[TBL] [Abstract][Full Text] [Related]
14. Systemic administration of agonist peptide blocks the progression of spontaneous CD8-mediated autoimmune diabetes in transgenic mice without bystander damage.
Bercovici N; Heurtier A; Vizler C; Pardigon N; Cambouris C; Desreumaux P; Liblau R
J Immunol; 2000 Jul; 165(1):202-10. PubMed ID: 10861053
[TBL] [Abstract][Full Text] [Related]
15. Langerhans cells activate naive self-antigen-specific CD8 T cells in the steady state.
Mayerova D; Parke EA; Bursch LS; Odumade OA; Hogquist KA
Immunity; 2004 Sep; 21(3):391-400. PubMed ID: 15357950
[TBL] [Abstract][Full Text] [Related]
16. CD8+ T lymphocytes in double alpha beta TCR transgenic mice. II. Competitive fitness of dual alpha beta TCR CD8+ T lymphocytes in the peripheral pools.
Legrand N; Freitas AA
J Immunol; 2001 Dec; 167(11):6158-64. PubMed ID: 11714775
[TBL] [Abstract][Full Text] [Related]
17. Quantitative PCR for detection of the OT-1 transgene.
Wright KO; Murray DA; Crispe NI; Pierce RH
BMC Immunol; 2005 Aug; 6():20. PubMed ID: 16120215
[TBL] [Abstract][Full Text] [Related]
18. Dual T cell receptor expressing CD8+ T cells with tumor- and self-specificity can inhibit tumor growth without causing severe autoimmunity.
Weinhold M; Sommermeyer D; Uckert W; Blankenstein T
J Immunol; 2007 Oct; 179(8):5534-42. PubMed ID: 17911640
[TBL] [Abstract][Full Text] [Related]
19. RAG-dependent peripheral T cell receptor diversification in CD8+ T lymphocytes.
Serra P; Amrani A; Han B; Yamanouchi J; Thiessen SJ; Santamaria P
Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15566-71. PubMed ID: 12432095
[TBL] [Abstract][Full Text] [Related]
20. Central tolerance to self-antigen expressed by cortical epithelial cells.
Mayerova D; Hogquist KA
J Immunol; 2004 Jan; 172(2):851-6. PubMed ID: 14707055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
